Clinical Trial Update: Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer

View source ↗

Summary

This clinical trial evaluates methylation markers for early detection and minimal residual disease monitoring in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Beijing Haidian Hospital | Conditions: Lung Cancer (NSCLC) | Status: RECRUITING